drugset / Trial / NCT01294644

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

NCT01294644

Phase 3 Completed 360 enrolled Kythera Biopharmaceuticals Bayer · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).

Timeline

Start
2011-01
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Deoxycholic Acid Small molecule 1 mg/m2 Other
Subject Deoxycholic Acid Small molecule 2 mg/m2 Other

Indications

No indication recorded.